Lexicon Genetics extends gene targeting technology agreement.Lexicon Genetics, Inc. (The Woodlands, TX) has extended its OmniBank Universal agreement with Boehringer Ingelheim Pharmaceuticals, Inc. Under the terms of the agreement, Boehringer Ingelheim will continue its access to Lexicon's OmniBank library through February 2004. Boehringer Ingelheim will also continue to have access to gene knockouts generated under Lexicon's patented gene targeting Gene targeting is a genetic technique that uses homologous recombination to change an endogenous gene. The method can be used to delete a gene, remove exons, and introduce point mutations. Gene targeting can be permanent or conditional. technologies with genetic alterations directed at specific drug targets of interest, and access to drug target validation data generated by Lexicon for specified targets. Financial terms of the arrangement were not disclosed.
Lexicon Genetics is a biopharmaceutical company focused on the discovery of breakthrough treatments for human disease. Lexicon is using gene knockout technology to systematically discover the physiological functions and medical uses of genes. The Company's gene function discoveries fuel therapeutic discovery programs in cardiovascular disease Cardiovascular disease
Disease that affects the heart and blood vessels.
Mentioned in: Lipoproteins Test
cardiovascular disease , diabetes, obesity, immune disorders, neurological disease Noun 1. neurological disease - a disorder of the nervous system
nervous disorder, neurological disorder
disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder"; and cancer. Lexicon has established drug discovery alliances and functional genomics Noun 1. functional genomics - the branch of genomics that determines the biological function of the genes and their products
genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) collaborations with leading pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , research institutes and academic institutions throughout the world to commercialize its technology and further develop its discoveries.
Lexicon Genetics, Inc.